EcoDrugPlus

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSMAUG00000003294
Gene Symbol: FNTA
1 Cross references
221 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSMAUG00000001088
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein

Ensembl ID : ENSMAUG00000011162
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSMAUG00000014645
Gene Symbol: FGF2
4 Cross references
117 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSMAUG00000018100
Gene Symbol: FGFR1
3 Cross references
289 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSMAUG00000012248
Gene Symbol: FGFR2
1 Cross references
217 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSMAUG00000012735
Gene Symbol: FGFR3
4 Cross references
196 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSMAUG00000011508
Gene Symbol: FGFR4
4 Cross references
123 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSMAUG00000006859
Gene Symbol: FLT1
4 Cross references
198 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSMAUG00000014271
Gene Symbol: FLT4
4 Cross references
195 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSMAUG00000003502
Gene Symbol: FOLH1B
3 Cross references
210 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSMAUG00000005204
Gene Symbol: FSHR
2 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).